特发性 CD4 T 细胞淋巴细胞减少症的临床试验
总计1387个结果
-
Nevada Cancer InstituteCLL Topics终止
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; The Affiliated Hospital Of Guizhou Medical University 和其他合作者招聘中
-
AstraZeneca完全的复发/难治性外周 T 细胞淋巴瘤 | 复发/难治性经典霍奇金淋巴瘤意大利, 瑞典, 美国, 台湾, 大韩民国, 英国, 澳大利亚, 法国, 新加坡
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
The Lymphoma Academic Research Organisation完全的
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)完全的
-
Royal Marsden NHS Foundation Trust未知外周 T 细胞淋巴瘤 (PTCL)
-
Ruijin Hospital尚未招聘
-
Bristol-Myers Squibb招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing... 和其他合作者招聘中
-
Ruijin HospitalThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province Cancer Hospital; The First Affiliated Hospital of Anhui Medical University 和其他合作者尚未招聘淋巴瘤 | 边缘区淋巴瘤 | 间变性大细胞淋巴瘤 | 血管免疫母细胞性T细胞淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 粘膜相关淋巴组织淋巴瘤 | 血管内大 B 细胞淋巴瘤 | 结外淋巴瘤 | NK/T 细胞淋巴瘤,鼻和鼻型中国
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and Technology完全的
-
Neumedicines Inc.National Cancer Institute (NCI)未知
-
M.D. Anderson Cancer CenterUniversity of Pittsburgh; Rush University Medical Center; Boston Medical Center; Vanderbilt University... 和其他合作者完全的
-
Sorrento Therapeutics, Inc.撤销弥漫性大 B 细胞淋巴瘤 | 胆道癌 | 外周T细胞淋巴瘤 | 结外 NK T 细胞淋巴瘤,鼻
-
Memorial Sloan Kettering Cancer Center完全的CD34 Selected Peripheral Blood Stem Cell Graft美国
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.招聘中
-
Sun Yat-sen University招聘中
-
Memorial Sloan Kettering Cancer CenterUniversity of Nebraska完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.完全的
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital; The Affiliated... 和其他合作者招聘中诱导化疗 | 急性T淋巴细胞白血病 | T 细胞淋巴母细胞淋巴瘤白血病 | T 细胞/骨髓混合表型急性白血病中国
-
Walter Hanel主动,不招人复发性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 复发性原发性皮肤 T 细胞非霍奇金淋巴瘤 | 难治性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 难治性间变性大细胞淋巴瘤 | T 细胞非霍奇金淋巴瘤 | 难治性原发性皮肤 T 细胞非霍奇金淋巴瘤 | 复发性间变性大细胞淋巴瘤 | 复发性转化蕈样肉芽肿 | 难治性转化蕈样肉芽肿美国
-
Affimed GmbHArtiva Biotherapeutics, Inc.招聘中
-
Sun Yat-sen University完全的放疗 | 信蒂利单抗 | 安罗替尼 | 自然杀伤/T 细胞淋巴瘤,鼻腔和鼻腔型 | 早期 | 聚乙二醇门冬酶 | 第二阶段 | 打开中国
-
The First Affiliated Hospital with Nanjing Medical...未知
-
University of MiamiNational Cancer Institute (NCI)终止
-
Sorrento Therapeutics, Inc.招聘中
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma Foundation完全的
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLC撤销
-
National Cancer Institute (NCI)主动,不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 晚期原发性皮肤 T 细胞非霍奇金淋巴瘤 | 复发性 3a 级滤泡性淋巴瘤 | 复发性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 复发性蕈样肉芽肿 | 复发性原发性皮肤 T 细胞非霍奇金淋巴瘤 | 难治性 1 级滤泡性淋巴瘤 | 难治性 2 级滤泡性淋巴瘤 | 难治性 3a 级滤泡性淋巴瘤 | 难治性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | IB 期蕈样肉芽肿 AJCC v7 | II 期蕈样肉芽肿 AJCC v7 | III 期皮肤 T 细胞非霍奇金淋巴瘤 | III 期蕈样肉芽肿 AJCC v7 | IV 期皮肤 T 细胞非霍奇金淋巴瘤 | IV 期蕈样肉芽肿 AJCC v7 | 复发性滤泡辅助性 T... 及其他条件美国, 加拿大
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.招聘中